🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial will study the effectiveness of nasal steroids for the treatment ...
Status
Completed
Location
University of Arizona
Start Date
2010-09
Trial ID
NCT01118312
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of short rag...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-20
Trial ID
NCT02478398
This purpose of this study is to determine the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00562159
The purpose of the study is to investigate the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00550550
This study is an open label, single dose, single site, randomized, cross ov...
Status
Completed
Location
Quotient Clinical
Start Date
2011-06
Trial ID
NCT01371786
Treatments Being Tested
This study is to assess the Onset of Action and Efficacy of azelastine hydr...
Status
Completed
Location
Cliantha Research
Start Date
2023-10-30
Trial ID
NCT06126952
The study will compare the safety and efficacy of a generic mometasone nasa...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT02109185
To evaluate the therapeutic equivalence of the lest formulation of Mometaso...
Status
Completed
Location
Isis Clinical Research
Start Date
2014-01
Trial ID
NCT02125253
Treatments Being Tested
Background: Eosinophilic esophagitis ( EoE ) is a disease entity which has...
Status
Terminated
Location
ENT dept, NÄL Hospital
Start Date
2014-04
Trial ID
NCT02113267
Treatments Being Tested
A real world evidence study that aims to understand the impact of RYALTRIS®...
Status
Withdrawn
Location
Community and Patient Preference Research Pty Ltd
Start Date
2021-11-17
Trial ID
NCT05129306
Treatments Being Tested